![Mark Longer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Mark A. Longer worked as a Senior Director-Regulatory Affairs at Amylin Pharmaceuticals, Inc. from 2007 to 2013.
He then worked as an Executive Director-Regulatory Affairs at Ardea Biosciences, Inc. from 2013 to 2015.
After that, he worked as a VP-Regulatory Affairs & Quality Assurance at Mast Therapeutics, Inc. He also worked as a VP-Program Planning & Management at Napo Pharmaceuticals, Inc. from 2006 to 2007.
Dr. Longer holds a doctorate degree from the University of Wisconsin and an undergraduate degree from The College of Wooster.
Antiguos cargos conocidos de Mark Longer.
| Empresas | Cargo | Fin |
|---|---|---|
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Consejero General | 01/02/2015 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Consejero General | 01/01/2013 |
Napo Pharmaceuticals, Inc.
 Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets human gastrointestinal pharmaceuticals | Corporate Officer/Principal | 01/08/2007 |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Consejero General | - |
Formación de Mark Longer.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
52
Relaciones de 1er grado
6
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets human gastrointestinal pharmaceuticals | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
The College of Wooster
 The College of Wooster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Bolsa de valores
- Insiders
- Mark Longer
Elige MarketScreener 
